Saudi Arabia's Ministry of Industry has reportedly announced the signing of a memorandum of understanding (MoU) with the Pfizer Foundation to manufacture viral and genetic vaccines in the Kingdom.
The agreement was signed on the sidelines of the first day of the Riyadh Global Medical Biotechnology Summit 2021 (RGMBS), which is being held under the auspices of Crown Prince Muhammad Bin Salman. Minister of the National Guard Prince Abdullah Bin Bandar inaugurated the virtual event, as per reports.
The Ministry of Industry said that the tripartite agreement (MoU), which was signed between the Ministry of Industry, the King Abdullah International Medical Research Center (KAIMRC) and the Pfizer Foundation, aimed at building the foundations for the manufacture of viral and genetic vaccines in the Kingdom, as well as providing technical support for the establishment of the human cell platform.
The Riyadh Global Medical Biotechnology Summit 2021is organized by KAIMRC at the Department of Health Affairs of the Ministry of National Guard in cooperation with the Health Sciences Faculty of King Saud University. Several eminent international speakers who are pioneers and leaders of biotech companies at international levels are addressing the summit. The 3-day event is discussing the role of biotechnology in developing medicines, vaccines, and cellular and genetic treatments.